Atherosclerosis: Cell biology and lipoproteins

Current Opinion in Lipidology

Volumn 15, Issue 2, 2004, Pages 231-234

  Ares, Mikko P S ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b Malmö University Hospital   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOCOSAHEXAENOIC ACID; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PROSTAGLANDIN SYNTHASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CYTOLOGY; EDITORIAL; PRIORITY JOURNAL;

ANIMALS; ARTERIOSCLEROSIS; CELLS, CULTURED; HUMANS; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MICE;

EID: 1842557512     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200404000-00019     Document Type: Editorial

References (15)

1. Napoleone E, Di Santo A, Camera M, et al. Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes. Circ Res 2000; 86:139-143.
2. Hayek T, Pavlotzky E, Hamoud S, et al. Tissue angiotensin-converting- enzyme (ACE) deficiency leads to a reduction in oxidative stress and in atherosclerosis: studies in ACE-knockout mice type 2. Arterioscler Thromb Vasc Biol 2003; 23:2090-2096.
3. Kowala MC, Recce R, Beyer S, Aberg G. Regression of early atherosclerosis in hyperlipidemic hamsters induced by fosinopril and captopril. J Cardiovasc Pharmacol 1995; 2:179-186.
4. Endemann G, Pronzcuk A, Friedman G, et al. Monocyte adherence to endothelial cells in vitro is increased by β-VLDL. Am J Pathol 1987; 128:1-6.
5. Lin JH, Zhu Y, Liao HL, et al. Induction of vascular cell adhesion molecule-1 by low-density lipoprotein. Atherosclerosis 1996; 127:185-194.
6. Han KH, Chen Y, Chang MK, et al. LDL activates signaling pathways leading to an increase in cytosolic free calcium and stimulation of CD11b expression in monocytes. J Lipid Res 2003; 44:1332-1340.
7. Björkerud S, Björkerud B. Lipoproteins are major and primary mitogens and growth promoters for human arterial smooth muscle cells and lung fibroblasts in vitro. Arterioscler Thromb 1994; 14:288-298.
8. Zhao D, Letterman J, Schreiber BM. β-migrating very low density lipoprotein (βVLDL) activates smooth muscle cell mitogen-activated protein (MAP) kinase via G protein-coupled receptor-mediated transactivation of the epidermal growth factor (EGF) receptor. Effect of MAP kinase activation on βVLDL plus EGF-induced cell proliferation. J Biol Chem 2001; 276:30579-30588.
9. Lipskaia L, Pourci M-L, Deloménie C, et al. Phosphatidylinositol 3-kinase and calcium-activated transcription pathways are required for VLDL-induced smooth muscle cell proliferation. Circ Res 2003; 92:1115-1122.
10. Pal S, Semorine K, Watts GF, Mamo J. Identification of lipoproteins of intestinal origin in human atherosclerotic plaque. Clin Chem Lab Med 2003; 41:792-795.
11. Fu Y, Huang Y, Bandyopadhyay S, et al. LDL immune complexes stimulate LDL receptor expression in U937 histiocytes via extracellular signal-regulated kinase and AP-t. J Lipid Res 2003; 44:1315-1321.
12. Lee JY, Ye J, Gao Z, et al. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem 2003; 278:37041-37051.
13. Burgess JW, Boucher J, Neville TA, et al. Phosphatidylinositol promotes cholesterol transport and excretion. J Lipid Res 2003; 44:1355-1363.
14. Demasi M, Cleland LG, Cook-Johnson RJ, et al. Effects of hypoxia on monocyte inflammatory mediator production: dissociation between changes in cyclooxygenase-2 expression and eicosanoid synthesis. J Biol Chem 2003; 278:38807-38816.
15. Rask-Madsen C, Dominguez H, et al. Tumor necrosis factor-α inhibits insulin's stimulating effect on glucose uptake and endothelium- dependent vasodilation in humans. Circulation 2003; 108:1815-1821.